New insider activity at Viemed Healthcare ( (VMD) ) has taken place on August 13, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
President Michael Moore has recently sold 50,090 shares of Viemed Healthcare stock, amounting to a total transaction value of $367,159.
Recent Updates on VMD stock
Viemed Healthcare recently reported robust financial results for Q2 2025, with a 14.7% increase in net revenues and a 115.1% rise in net income. The company’s strategic acquisition of Lehan Medical Equipment has bolstered its growth prospects, allowing it to raise its full-year revenue and adjusted EBITDA guidance. Viemed’s core operations, particularly in ventilation and sleep therapy, have shown strong performance, contributing to the positive outlook. Despite a slight decline in gross margins and challenges in the staffing sector, the company’s overall financial health remains strong, supported by successful share repurchases and a solid cash position. Analysts have responded positively, with a recent rating of ‘Outperform,’ driven by Viemed’s strategic growth initiatives and positive earnings call sentiment.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s strong financial performance and strategic growth initiatives, including acquisitions and share repurchases, are key strengths. The technical indicators suggest potential short-term caution due to overbought signals. The valuation is moderate, and the positive earnings call further supports a favorable outlook. Overall, the stock presents a balanced investment opportunity with solid growth prospects.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
YTD Price Performance: -8.49%
Average Trading Volume: 231,911
Technical Sentiment Signal: Buy
Current Market Cap: $288.6M